Ignite Creation Date:
2024-05-05 @ 4:43 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00309517
Status:
TERMINATED
Last Update Posted:
2006-04-03
First Post:
2006-03-31
Brief Title:
Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C
Sponsor:
Austrian Breast Colorectal Cancer Study Group
Organization:
Austrian Breast Colorectal Cancer Study Group
Study Overview
Official Title:
A Prospectively Randomized Study on Neoadjuvant Radio-Chemotherapy in Patients With Operated Rectal Carcinoma Dukes B and C pT2 pN1-3 pT3-4 pN0-3 M0
Status:
TERMINATED
Status Verified Date:
2000-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical investigation examined the influence of preoperative radiotherapy in combination with postoperative 5-fluorouracil leucovorin chemotherapy vs 5-fluorouracil leucovorin MAb 17-1A chemo-immunotherapy on patients local recurrence rate and overall survival time following surgery for rectal carcinoma Dukes B or C T2-4 N0-3 M0
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None